Day: October 7, 2024

Main Street Financial Services Corp. Announces Dividend Reinvestment Plan for Shareholders

Written by Customer Service on October 7, 2024. Posted in Public Companies.

WOOSTER, Ohio, Oct. 07, 2024 (GLOBE NEWSWIRE) — Main Street Financial Services Corp. (OTCQX:MSWV), (the “Company”), the holding company parent of Main Street Bank Corp. (the “Bank”) announced today that it has implemented a Dividend Reinvestment Plan (DRIP) as part of the Computershare Investment Plan. The DRIP will provide eligible Main Street Financial Services Corporation shareholders with the opportunity and convenience of automatic reinvestment of dividends in reinvestment shares. For more information or if you would like to enroll in the program, please visit the transfer agent’s website www.computershare.com/investor and search Main Street Financial Services or contact your investment broker. About MSWV: Main Street Financial Services Corp. is a $1.4 billion holding company headquartered in Wooster, Ohio. Its primary subsidiary,...

Territorial Bancorp Urges Shareholders to Vote FOR Hope Bancorp Merger

Written by Customer Service on October 7, 2024. Posted in Mergers And Acquisitions.

Compelling Combination with Hope Bancorp Creates Substantial Value for All Territorial Shareholders and Significant Benefits for Hawai‘i and Territorial Customers, Employees and Communities Preliminary Indication of Interest by Outside Investor Group, Blue Hill, is Illusory, Non-Binding and Highly Conditional — Exposing Territorial Shareholders to Significant Uncertainty and Downside Risk Launches http://www.territorialandhopecombination.com/ HONOLULU, Oct. 07, 2024 (GLOBE NEWSWIRE) — Territorial Bancorp Inc. (NASDAQ: TBNK) (“Territorial” or the “Company”) today announced it is mailing a letter to Territorial shareholders in connection with the Company’s upcoming Special Meeting of Stockholders (the “Special Meeting”) to vote on the proposed merger with Hope Bancorp, Inc. (NASDAQ: HOPE) (“Hope Bancorp”) and related proposals....

Managed Network Services Market to Witness 13.7% CAGR by 2031 | SkyQuest Technology

Written by Customer Service on October 7, 2024. Posted in Mergers And Acquisitions.

Westford, USA, Oct. 07, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Managed Network Services Market will attain the value of USD 849.19 billion by 2031, with a CAGR of 13.7% during the forecast period (2024-2031). The managed network services market is growing exponentially, with several major factors driving the rise of Internet of Things (IoT) solution. Also, increases in information technology costs are trying to resolve the costs of their basic systems and, with increasing procedures, making managed services an attractive option for businesses. They provide fuel for the growth of the market, as organizations are looking to increase their networks, security and performance. Download a detailed overview:https://www.skyquestt.com/sample-request/managed-network-services-market Browse in-depth TOC on ” Managed Network Services...

Prenetics Announces Second Quarter 2024 Financial Results

Written by Customer Service on October 7, 2024. Posted in Earnings Releases And Operating Results.

Cost Optimization Boosted Gross Margin by 21.7% YoY in H1 2024Enters U.S. Health Market in October with IM8, a New Health and Wellness BrandRe-affirms Revenue Target to Exceed US$33 million for FY 2024 CHARLOTTE, N.C., Oct. 07, 2024 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced unaudited financial results for the second quarter ended June 30, 2024, along with recent business updates. Second Quarter 2024 Financial HighlightsRevenue from continuing operations of US$5.9 million, as compared to US$6.5 million in the second quarter 2023 attributable to clinical segment revenues, which are anticipated in the latter half of the year. Gross profit from continuing operations of US$3.8 million, an increase of 23.6% as compared to the second quarter...

Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease

Written by Customer Service on October 7, 2024. Posted in Public Companies.

– KB-7898, a p300 KAT inhibitor, is the Company’s first development candidate for autoimmune diseases and originates from its proprietary discovery engine that decodes complex transcription factor regulatory networks – – Preclinical data for KB-7898 will be presented at ACR Convergence 2024 – SAN MATEO, Calif. and CAMBRIDGE, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and autoimmune diseases driven by deregulated transcription, today announced the nomination of a development candidate, KB-7898, a p300 lysine acetyltransferase (KAT) inhibitor for the potential treatment of Sjögren’s disease, a chronic autoimmune disease that is characterized by the production of autoantibodies, chronic inflammation and lymphocytic...

Avid and Wolftech to Empower Digital-First, Story-Driven Newsroom Collaboration

Written by Customer Service on October 7, 2024. Posted in Mergers And Acquisitions.

Broadcast technology leaders join forces to enable news production teams to accelerate storytelling – from pitch to publishBURLINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) — Avid®, the global leader in software solutions for professional media production, has today entered into a definitive agreement to acquire Wolftech Broadcast Solutions, the industry leader in cloud-based multiplatform planning and publishing news production solutions. This strategic move illustrates Avid’s focus on transforming news, sports, and live production workflows. The acquisition will allow Avid to combine its digital-first, end-to-end media solution with Wolftech’s expertise in story-centric workflow management. The integration of Wolftech and Avid is intended to enable news organizations to rapidly deliver stories through multiplatform...

FE International Advises Acquisition of B2B Database by Retail Operations Automator

Written by Customer Service on October 7, 2024. Posted in Mergers And Acquisitions.

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) — FE International, Inc., the global market leader in lower-middle-market technology mergers and acquisitions (M&A), announces the strategic acquisition of a leading ecommerce database by a premier Amazon retail automation platform. The database creates leads for B2B ecommerce vendors; it researches, curates, and validates data from dozens of sources to create a list of direct contacts from other vendors across various platforms, like Amazon, Shopify, and Walmart. The data is then converted to leads for users. The lead generation market is critical in B2B as it helps businesses identify and engage with potential customers, which can increase sales, revenue, and growth. The database provides critical industry data to vendors, allowing them to spend more time capitalizing on leads and...

Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines

Written by Customer Service on October 7, 2024. Posted in Mergers And Acquisitions.

Galecto will focus on cancer and liver disease, leveraging existing clinical stage asset GB1211 Bolsters pipeline by obtaining global rights to BRM-1420, a novel dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets of acute myeloid leukemia (AML) BRM-1420 has the potential for enhanced clinical effectiveness compared to FLT3 inhibitors alone and has shown synergistic effects with SOC in preclinical modelsBOSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced that, following an intensive strategic review process, Galecto has determined to focus on cancer and liver disease, leveraging its existing clinical stage asset GB1211, which has shown positive results in non-small cell...

Form 8.3 – Learning Technologies Group Plc

Written by Customer Service on October 7, 2024. Posted in Mergers And Acquisitions.

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Learning Technologies Group Plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an...

Haoxi Health Technology Limited Announces Preliminary Unaudited FY24 Financial Results with projected 72% Revenue Growth

Written by Customer Service on October 7, 2024. Posted in Earnings Releases And Operating Results.

BEIJING, Oct. 07, 2024 (GLOBE NEWSWIRE) — Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced preliminary unaudited financial results for the fiscal year ended June 30, 2024 (“FY24”). HAO projects revenue growth during FY24, which it attributes to the Company’s strategic development in online advertising solutions, particularly through short video formats and news feed ads. The Company’s proprietary data analysis software, Bidding Compass, enables it to optimize ad placements, which it believes has driven growth in both revenue and profit for FY24. Key financial highlights (projected preliminary, unaudited results) are provided as below:Revenue: Approximately $48.52 million for FY24, reflecting a 72% increase compared to $28.23 million...

Day: October 7, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice